SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068262
Filing Date
2024-08-13
Accepted
2024-08-13 16:13:57
Documents
61
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210867-10q_adial.htm   iXBRL 10-Q 542965
2 CERTIFICATION ea0210867ex31-1_adial.htm EX-31.1 12631
3 CERTIFICATION ea0210867ex31-2_adial.htm EX-31.2 12946
4 CERTIFICATION ea0210867ex32-1_adial.htm EX-32.1 5252
5 CERTIFICATION ea0210867ex32-2_adial.htm EX-32.2 5307
  Complete submission text file 0001213900-24-068262.txt   4221220

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20240630.xsd EX-101.SCH 41321
7 XBRL CALCULATION FILE adil-20240630_cal.xml EX-101.CAL 35570
8 XBRL DEFINITION FILE adil-20240630_def.xml EX-101.DEF 218320
9 XBRL LABEL FILE adil-20240630_lab.xml EX-101.LAB 394978
10 XBRL PRESENTATION FILE adil-20240630_pre.xml EX-101.PRE 212702
64 EXTRACTED XBRL INSTANCE DOCUMENT ea0210867-10q_adial_htm.xml XML 384378
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 241201614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)